ELEVANCE HEALTH INC (A58.DE) Stock Earnings & Estimates
Europe - FRA:A58 - US0367521038 - Common Stock
261.6 EUR
-6.7 (-2.5%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 121.867B 16.89% | 138.639B 13.76% | 156.595B 12.95% | 172.184B 9.95% | 178.062B 3.41% | 188.949B 6.11% | 210.815B 11.57% | 233.504B 10.76% | N/A | N/A | N/A | |
| EBITDA YoY % growth | 8.865B 12.03% | 10.457B 17.96% | 10.375B -0.78% | 11.558B 11.40% | 12.686B 9.76% | 13.886B 9.46% | 14.847B 6.92% | 16.199B 9.11% | 16.89B 4.27% | 17.449B 3.31% | 18.034B 3.35% | |
| EBIT YoY % growth | 7.711B 13.73% | 9.155B 18.73% | 8.7B -4.97% | 10.627B 22.15% | 11.638B 9.51% | 12.886B 10.72% | 12.468B -3.24% | N/A | N/A | N/A | N/A | |
| Operating Margin | 6.33% | 6.60% | 5.56% | 6.17% | 6.54% | 6.82% | 5.91% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 22.42 15.45% | 25.97 15.83% | 29.05 11.86% | 33.26 14.50% | 37.37 12.35% | 42.60 13.99% | 48.83 14.62% | 56.14 14.96% | 59.05 5.20% | 64.33 8.93% | 70.35 9.36% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 6.04 15.42% | 10.31 8.98% | 10.12 11.90% | 9.75 8.48% | 7.21 19.50% | 11.63 12.83% | 11.13 10.06% | 11.08 13.59% | 8.58 18.90% |
| Revenue Q2Q % growth | 42.489B 6.41% | 43.97B 4.26% | 45.08B 3.22% | 45.115B 5.29% | 45.048B 6.02% | 45.955B 4.51% | 46.905B 4.05% | 47.23B 4.69% | 47.22B 4.82% |
| EBITDA Q2Q % growth | 2.078B -33.78% | 3.48B 4.44% | 3.461B -3.78% | 3.21B -19.02% | 2.655B 27.77% | 3.754B 7.87% | 3.772B 8.99% | 3.587B 11.74% | 3.048B 14.80% |
| EBIT Q2Q % growth | 1.889B 29.12% | 3.313B 15.44% | 3.386B 25.31% | 3.27B 23.72% | 2.493B 31.97% | 3.731B 12.62% | 3.647B 7.71% | 3.517B 7.55% | 2.882B 15.60% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 8.99 19.39% | 8.52 | 0.47 | 5.47% |
| Q2 2023 Q2Q % growth | 9.04 12.44% | 8.88 | 0.16 | 1.75% |
| Q1 2023 Q2Q % growth | 9.46 14.67% | 9.35 | 0.11 | 1.13% |
| Q4 2022 Q2Q % growth | 5.23 1.75% | 5.24 | -0.01 | -0.20% |
| Q3 2022 Q2Q % growth | 7.53 10.90% | 7.22 | 0.31 | 4.30% |
| Q2 2022 Q2Q % growth | 8.04 14.37% | 7.82 | 0.22 | 2.84% |
| Q1 2022 Q2Q % growth | 8.25 17.69% | 7.89 | 0.36 | 4.54% |
| Q4 2021 Q2Q % growth | 5.14 102.36% | 5.16 | -0.02 | -0.46% |
| Q3 2021 Q2Q % growth | 6.79 61.67% | 6.43 | 0.36 | 5.53% |
| Q2 2021 Q2Q % growth | 7.03 -23.59% | 6.40 | 0.63 | 9.93% |
| Q1 2021 Q2Q % growth | 7.01 8.18% | 6.58 | 0.43 | 6.57% |
| Q4 2020 Q2Q % growth | 2.54 -34.54% | 2.55 | -0.01 | -0.21% |
| Q3 2020 Q2Q % growth | 4.20 -13.76% | 4.19 | 0.01 | 0.15% |
| Q2 2020 Q2Q % growth | 9.20 98.28% | 8.96 | 0.24 | 2.64% |
| Q1 2020 Q2Q % growth | 6.48 7.46% | 6.54 | -0.06 | -0.94% |
| Q4 2019 Q2Q % growth | 3.88 | 3.92 | -0.04 | -1.06% |
| Q3 2019 Q2Q % growth | 4.87 | 4.87 | 0.00 | 0.03% |
| Q2 2019 Q2Q % growth | 4.64 | 4.66 | -0.02 | -0.43% |
| Q1 2019 Q2Q % growth | 6.03 | 5.87 | 0.16 | 2.68% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 42.849B 7.29% | 43.042B | -193M | -0.45% |
| Q2 2023 Q2Q % growth | 43.672B 13.05% | 41.917B | 1.755B | 4.19% |
| Q1 2023 Q2Q % growth | 42.172B 10.70% | 41.24B | 932M | 2.26% |
| Q4 2022 Q2Q % growth | 39.929B 9.15% | 40.038B | -109M | -0.27% |
| Q3 2022 Q2Q % growth | 39.939B 11.49% | 39.479B | 460M | 1.17% |
| Q2 2022 Q2Q % growth | 38.632B 14.12% | 38.51B | 122M | 0.32% |
| Q1 2022 Q2Q % growth | 38.095B 17.63% | 37.727B | 368M | 0.98% |
| Q4 2021 Q2Q % growth | 36.581B 15.18% | 36.878B | -297M | -0.81% |
| Q3 2021 Q2Q % growth | 35.822B 14.90% | 35.652B | 170M | 0.48% |
| Q2 2021 Q2Q % growth | 33.851B 15.72% | 33.536B | 315M | 0.94% |
| Q1 2021 Q2Q % growth | 32.385B 9.12% | 33.272B | -887M | -2.67% |
| Q4 2020 Q2Q % growth | 31.76B 15.81% | 31.089B | 671M | 2.16% |
| Q3 2020 Q2Q % growth | 31.176B 16.82% | 30.111B | 1.065B | 3.54% |
| Q2 2020 Q2Q % growth | 29.253B 14.84% | 29.542B | -289M | -0.98% |
| Q1 2020 Q2Q % growth | 29.678B 20.27% | 28.885B | 793M | 2.75% |
| Q4 2019 Q2Q % growth | 27.424B | 27.368B | 56M | 0.20% |
| Q3 2019 Q2Q % growth | 26.687B | 26.134B | 553M | 2.12% |
| Q2 2019 Q2Q % growth | 25.473B | 25.12B | 353M | 1.41% |
| Q1 2019 Q2Q % growth | 24.676B | 24.463B | 213M | 0.87% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.09% | -2% | -0.01% | 0.29% |
| Revenue | 99166.4% | 1.73% | 0.1% | 2.8% |